Bicara Therapeutics Inc. (BCAX) KPIs and segments
BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.75−0.27 (-2.69%)
Close on Nov 16, 2026Market cap $645.19MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Bicara Therapeutics's business
Coming soon
This tab will track the numbers specific to Bicara Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?